Pharmacodynamics, pharmacokinetics and clinical efficacy of phosphodiesterase-5 inhibitors-Reference-Cited by-同舟云学术

Pharmacodynamics, pharmacokinetics and clinical efficacy of phosphodiesterase-5 inhibitors

Published:2016-10-21 Issue:2 Volume:13 Page:183-192
ISSN:1742-5255
Container-title:Expert Opinion on Drug Metabolism & Toxicology
language:en
Short-container-title:Expert Opinion on Drug Metabolism & Toxicology

Author:

Hong Jeong Hee¹²,Kwon Young Suk¹,Kim Isaac Yi¹

Affiliation:

1. Section of Urologic Oncology, Rutgers Cancer Institute of New Jersey and Division of Urology, Rutgers Robert Wood Johnson Medical School, Rutgers, The State University of New Jersey, New Brunswick, NJ, USA

2. Department of Urology, Dankook University College of Medicine, Cheonan, South Korea

Funder

funded

Publisher

Informa UK Limited

Subject

Pharmacology,Toxicology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425255.2017.1244265

Reference98 articles.

1. The likely worldwide increase in erectile dysfunction between 1995 and 2025 and some possible policy consequences

2. Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle

3. CHAPTER 1: THE MANAGEMENT OF ERECTILE DYSFUNCTION: AN AUA UPDATE

4. Guidelines on Male Sexual Dysfunction: Erectile Dysfunction and Premature Ejaculation

5. Newer Phosphodiesterase Inhibitors: Comparison with Established Agents

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Undeclared phosphodiesterase type 5 inhibitors (PDE5Is) in food supplements on the Croatian market analyzed by liquid chromatography time-of-flight mass spectrometry (LC-QTOF-MS);Microchemical Journal;2024-08

2. Differences in ocular adverse events associated with phosphodiesterase-5 inhibitors: a real-world pharmacovigilance study;Expert Opinion on Drug Safety;2024-05-16

3. Epidemiologic Features and Management of Sexual Dysfunctions in Infertile Men;Current and Future Advances in Male Infertility;2024

4. PDE5 inhibitors: breaking new grounds in the treatment of COVID-19;Drug Metabolism and Personalized Therapy;2023-08-24

5. PDE5 inhibitors: breaking new grounds in the treatment of COVID-19;Drug Metabolism and Personalized Therapy;2023-08-24